An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone had to stop taking Mounjaro (tirzepatide) for about three weeks around a breast reduction and now, five weeks after their last dose, their appetite has come back and they’re eating more — partly from anxiety and being off work. They’re asking whether they should restart the drug and, if so, at what dose, or whether they should stop it altogether. Mounjaro is the brand name for tirzepatide. It’s a prescription medication given by weekly injection that acts like two gut hormones that help control blood sugar and appetite. In plain terms: it tricks your body into feeling fuller and slows how quickly your stomach empties, so people tend to eat less and lose weight while on it. Doctors usually start at a low weekly dose and raise it slowly to reduce side effects like nausea. What the snippet shows is a personal, practical question, not a formal study. Guidance about restarting comes from how Mounjaro is dosed in clinical practice and the drug’s prescribing information. If you’ve missed several weeks, many clinicians treat you like a new start: you often restart at the lowest dose and re-titrate (slowly increase) to the prior dose, because your body can lose some tolerance and side effects like nausea can come back. There isn’t a large clinical trial specifically telling exactly how to restart after a 3–5 week gap, so doctors use general principles and individual judgment. Why this matters: appetite and weight can rebound fairly quickly after stopping these medicines, and restarting the same dose could cause unpleasant side effects. People recovering from surgery are already stressed and healing, so managing appetite, mood and recovery together is important. If you want to keep the medication, restarting conservatively helps protect you from nausea, dizziness, or other problems that might interfere with healing. If you’re thinking about stopping permanently, know that weight and appetite may return and you might need extra support from diet, mental-health care, or other medical strategies. Caveats and risks: don’t make changes on your own. Mounjaro is prescription-only and has potential side effects like nausea, vomiting, diarrhea, low blood sugar (especially if you also take diabetes meds), and rare but serious concerns clinicians monitor for. Surgery and recovery can change how medicines affect you, so your surgeon and the doctor who prescribes Mounjaro should both weigh in. If you have pancreatitis history, certain thyroid issues, or are pregnant/planning pregnancy, different rules apply. If anxiety is driving eating, treating the anxiety directly (therapy, coping strategies, or medication) can help whether or not you restart Mounjaro. Bottom line: talk with your prescriber and surgeon; most clinicians would restart at a lower dose and slowly ramp up rather than jump back to your prior dose. They’ll tailor the plan to your health, side-effect history, and recovery.
Source: r/Mounjaro